BRCA1 and breast cancer: Aside from those embryos with BRCA1 mutations, most embryos were predicted to have less than twofold OR of breast cancer (Fig. 2b), suggesting that PGT for breast cancer is most beneficial in scenarios with a pathogenic variant with high impact on disease risk5,6.